Aurigene brings over 25 years of expertise in small-molecule CDMO solutions, providing a streamlined, end-to-end approach to meet your development and manufacturing needs.
Our fully integrated services guide you from early-stage development through to regulatory approval, ensuring your project aligns with global standards and achieves successful market entry. Equipped with advanced cGMP facilities and a 4,100 m³ capacity, we manage projects of all scales, delivering high-quality outcomes on time and within scope.
Our team of 700+ skilled scientists has completed over 400 projects, combining technical insight with practical experience to drive your vision forward. Partnering with Aurigene means choosing a dedicated team committed to excellence, precision, and your project’s success every step of the way.
Our Small Molecule Development and Manufacturing Services:
Aurigene Pharmaceutical Services offers specialized small molecule development with capabilities in process optimization, solid form screening, and high-containment handling. Our advanced facilities support complex chemistries, including cryogenic and high-pressure reactions, as well as continuous manufacturing for efficient scaling. With dedicated support for peptides, steroids, and mPEG derivatives, our process development labs and containment facilities ensure precision and safety at every stage. Aurigene ensures a seamless pathway from early development through to large-scale manufacturing, offering smooth tech transfer, in-depth analytical development, and robust IP and regulatory support for reliable market readiness.
Development Services
Manufacturing Services
Specialized Chemistry
Why Aurigene Pharmaceutical Services?
20+
years’ experience
900+
scientists
125+
global clients
600+
projects
19
NCEscommercialized
16
USFDA inspectedcGMP facilities
6
Biologicscommercialized
3
manufacturing countriesUK, Mexico, India
Our Global Manufacturing Footprint
Drug Substance cGMP Facilities
- CTO-Mexico: Large-scale small molecule APIs, steroids and mPEG Alcohol
- CTO-Mirfield: Small molecule, prostaglandin and mPEG derivatives
- CTO-1, India: High potent and small molecule APIs
- CTO-2, India: Small molecule APIs and Nutraceuticals
- CTO-3, India: Low and medium scale small molecule APIs
- CTO-5, India: Large-scale small molecule APIs
- CTO-6, India: Small molecule, peptide, spray drying and high potent
- CTO-SEZ, India: Small molecule, continuous manufacturing, spray drying and high potent
Drug Product cGMP Facilities
- FTO-2: Regular OSDs (oral solid dosage forms)
- FTO-3: Regular OSDs
- FTO-7: Cyto parenterals and cyto and harmonal OSDs
- FTO-9: Non- cyto parenterals ophthalmics and BFS
- FTO-11: Parenterals cyto and non-cyto
- FTO-PU1: Regular OSDs
- FTO-PU2: Topicals, soft gelatin, and potent OSDs
Virtual Tour
Hyderabad R and D Center
Bangalore R and D Center
Connect with our scientific experts for your drug discovery, development, and manufacturing needs
We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.
Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.
Methoxy Polyethylene Glycol (m-PEGs)
Aurigene Pharmaceutical Services is a leader in the synthesis of activated MethoxyPolyethyleneGlycol(m-PEGs), With a comprehensive product range and customized services. ...
Read More
Base mediated spirocyclization of quinazoline: one-step synthesis of spiro-isoindolinone dihydroquinazolinones
2020
A novel approach for the spiro-isoindolinone dihydroquinazolinones has been demonstrated from 2- aminobenzamide and 2-cyanomethyl benzoate in the presence of KHMDS as a base to get moderate yields. The reaction has been screened in various bases followed by solvents and a gram scale reaction has also been executed under the given conditions. Based on the controll...
Read More-
Ultrasound assisted rapid synthesis of mefenamic acid based indole derivatives under ligand free Cu-catalysis: Their pharmacological evaluation
2005
An improved and rapid synthesis of mefenamic acid based indole derivatives has been achieved via the ligand free Cu-catalyzed coupling-cyclization method under ultrasound irradiation. This simple, straightforward and inexpensive one-pot method involved the reaction of a terminal alkyne derived from mefenamic acid with 2- iodosulfanilides in the presence of CuI ...
Read More -
Formal synthesis of Cladospolide C & epi-Cladospolide C using R- (þ)-g-valerolactone as a chiral synthon
2005
The formal synthesis of Cladospolide-C and its analog is achieved by using enantiopure (R)-g evalerolactone 10. The significant points of this synthesis are the stereoselective dihydroxylation of a, bunsaturated ester 16 using Sharpless protocol, Wittig olefination of g evalerolactol 6 with triphenylphosphonium iodide salt 7, one pot selective oxidation ...
Read More -
Amberlite-15 promoted an unprecedented aza Michael rearrangement for one pot synthesis of dihydroquinazolinone compounds
2005
A new one pot multicomponent annulation strategy for the synthesis of various dihydroquinazolinone compounds has been developed using Amberlite-15 as a catalyst, giving good to moderate yields. In this reaction the substrate scope for amines and aldehydes was also investigated. The reaction has been checked on a large scale ...
Read More
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
Leaving already?
Don't forget to join us at
CPHI Worldwide 2023.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market